2020
DOI: 10.1111/jsap.13252
|View full text |Cite
|
Sign up to set email alerts
|

Administration of nitrofurantoin in dogs with lower urinary tract infections: 14 cases (2013‐2019)

Abstract: The purpose of this study was to describe the clinical use of nitrofurantoin in client-owned dogs with lower urinary tract infections. The primary aim was to describe the patient population, dosage, treatment duration, outcome and side effects. Materials and MethOds: Medical records in an institution were retrospectively reviewed from July 2013 to January 2019. results: Nitrofurantoin was prescribed in this clinical population of 14 client-owned dogs for lower urinary tract infections. Recurrent urinary tract … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 26 publications
1
13
0
Order By: Relevance
“…and Pseudomonas spp., as these bacteria are intrinsically resistant to NIT [ 82 ]. In contrast to earlier reports, the macrocrystalline formulation of NIT prescribed today rarely causes gastrointestinal side effects [ 80 , 83 ]. Clinical treatment with NIT also requires excellent compliance from the owner, as the drug must be administered every 8 h due to its low plasma concentration [ 21 , 78 , 83 ].…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…and Pseudomonas spp., as these bacteria are intrinsically resistant to NIT [ 82 ]. In contrast to earlier reports, the macrocrystalline formulation of NIT prescribed today rarely causes gastrointestinal side effects [ 80 , 83 ]. Clinical treatment with NIT also requires excellent compliance from the owner, as the drug must be administered every 8 h due to its low plasma concentration [ 21 , 78 , 83 ].…”
Section: Discussionmentioning
confidence: 78%
“…Nitrofurantoin is recommend by current guidelines as a second-line antimicrobial in sporadic bacterial cystitis [ 21 ]. However, due to its toxicity and poor pharmacokinetic properties, it should only be considered in cases of UTI caused by MDR bacteria [ 78 , 79 , 80 , 81 ]. The excellent efficacy of NIT is also supported by our data, as 94.5% of the MDR isolates identified in this study were susceptible to this drug.…”
Section: Discussionmentioning
confidence: 99%
“…Nitrofurantoin is considered very effective against E. coli [ 67 , 68 ] and a reasonable alternative to fluoroquinolones and β-lactams in the treatment of UTIs in human medicine and small-animal clinical practice [ 67 , 69 , 70 ]. As expected, all E. coli isolates were susceptible to this antimicrobial, and only three K. pneumoniae isolates were resistant to nitrofurantoin.…”
Section: Discussionmentioning
confidence: 99%
“…For this study, we examined antibiotics that are clinically relevant and are used to treat human and animal infections caused by E. coli , including nitrofurantoin, ciprofloxacin, and fosfomycin ( Wagenlehner et al 2013 ; Pérez et al 2014 ; Huttner et al 2015 ; Papich 2017 ; Huttner et al 2018 ; Kot 2019 ; Drekonja et al 2021 ; Leuin et al 2021 ). We also included the antibiotic tetracycline, which is used for other types of infections ( Roberts 2003 ) and is commonly found at low concentrations in many natural environments ( Liu et al 2018 ; Song et al 2021 ; Wang et al 2021 ). For each of these antibiotics, the selection was carried out over a wide-range of subMIC antibiotic levels to determine the minimal selective concentration (MSCs), where MSC is defined as the lowest antibiotic concentration where the fitness cost of the resistance is balanced by the antibiotic-conferred selection for the resistant mutant ( Gullberg et al 2011 ).…”
Section: Introductionmentioning
confidence: 99%